RecruitingNot ApplicableNCT05147909

Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity


Sponsor

University of Texas Southwestern Medical Center

Enrollment

124 participants

Start Date

Sep 14, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Studies in mice demonstrated that dietary phosphate (Pi) loading that mimic the level of US adult consumption leads to reduced spontaneous locomotor activity, exercise capacity, and reduced resting metabolic rate when in normal mice by impairing skeletal muscle mitochondrial function and fat oxidation. However, relevance of this findings in humans remains unknown.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Sodium Chloride and Sodium Phosphate for people with phosphate overload, physical inactivity, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTSodium Phosphate

Sodium Phosphate 2 capsules daily (containing a total of 500 mg of Pi, 372mg of sodium)

DIETARY_SUPPLEMENTSodium Chloride

Sodium Chloride 2 capsules daily (NaCl, containing a total of 372mg of sodium)


Locations(1)

University of Texas Southwestern

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05147909


Related Trials